ZFAS1 and glioma: Additionally, increased expression of ZFAS1 was closely correlated with poorer overall survival in colorectal cancer, gastric cancer, glioma, osteosarcoma, oesophageal squamous cell carcinoma, ovarian cancer, and NSCLC.